The search engine found new reagents in the following categories.
SARS-CoV-2
|
NRH-21765
|
Pooled Human Serum Sample, Pfizer/Pfizer/Moderna Vaccines (1.0 mL)
|
BEI Level 2
|
November
2022
|
|
NR-58706
|
SARS-Related Coronavirus 2
Isolate hCoV-19/Japan/TY41-716/2022 (Lineage BA.2.75; Omicron Variant)
|
BEI Level 3
|
November
2022
|
|
NR-55609
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/PHC248/2021 (Lineage B.1.526; Iota Variant)
|
BEI Level 3
|
November
2022
|
|
NR-58716
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP34985/2022 (Lineage BF.5; Omicron Variant)
|
BEI Level 3
|
October
2022
|
|
NR-58616
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/COR-22-063113/2022 (Lineage BA.5; Omicron Variant)
|
BEI Level 3
|
October
2022
|
|
NR-58717
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP35538/2022 (Lineage BA.4.6; Omicron Variant) (WCCM)
|
BEI Level 3
|
October
2022
|
|
NR-58715
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP35538/2022 (Lineage BA.4.6; Omicron Variant)
|
BEI Level 3
|
October
2022
|
|
NR-56225
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP06587/2021 (Lineage B.1.621.1; Mu Variant)
|
BEI Level 3
|
September
2022
|
|
NR-55698
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/WI-UW-4340/2021 (Lineage B.1.621)
|
BEI Level 3
|
September
2022
|
|
NR-56327
|
SARS-Related Coronavirus 2
Isolate hCoV-19/South Africa/KRISP-K020179/2021, clone PP6 (Lineage C.1.2)
|
BEI Level 3
|
September
2022
|
|
NR-58646
|
Spike Glycoprotein (Stabilized) from SARS-Related Coronavirus 2, BA.4 Lineage (Omicron Variant) with C-Terminal Histidine and Avi Tags, Recombinant from HEK293 Cells
SARS-Related Coronavirus 2
|
BEI Level 1
|
September
2022
|
|
NRH-21761
|
Pooled Human Serum Sample, Johnson and Johnson/Moderna Vaccines (1.0 mL)
|
BEI Level 2
|
August
2022
|
|
NRH-21762
|
Pooled Human Serum Sample, Johnson and Johnson/Pfizer Vaccines (1.0 mL)
|
BEI Level 2
|
August
2022
|
|
NRH-21760
|
Pooled Human Serum Sample, Novavax/Novavax/Pfizer Vaccines (1.0 mL)
|
BEI Level 2
|
August
2022
|
|
NR-56309
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/VA-NIDDL-48553/2021 (Lineage B.1.637)
|
BEI Level 3
|
August
2022
|
|
NR-56803
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP30386/2022 (Lineage BA.4; Omicron Variant)
|
BEI Level 3
|
August
2022
|
|
NR-56133
|
Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, Wuhan-Hu-1 with C-Terminal Histidine Tag, Recombinant from HEK293 Cells
SARS-Related Coronavirus 2
|
BEI Level 1
|
August
2022
|
|
NR-54971
|
SARS-Related Coronavirus 2
Isolate hCoV-19/England/204820464/2020 in Calu-3 (Lineage B.1.1.7; Alpha Variant)
|
BEI Level 3
|
August
2022
|
|
NR-53885
|
SARS-Related Coronavirus 2
Isolate hCoV-19/Singapore/12/2020 (Δ382) (Lineage B)
|
BEI Level 3
|
August
2022
|
|
NR-55400
|
Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, E484K Variant with C-Terminal Histidine Tag, Recombinant from HEK293 Cells
SARS-Related Coronavirus 2
|
BEI Level 1
|
August
2022
|